BACKGROUND: The cellular immune responses that protect against tuberculosis have not been identified. METHODS: We assessed baseline interferon γ (IFN‐γ) and lymphocyte proliferation assay (LPA) responses to antigen 85 (Ag85), early secretory antigenic target 6 (ESAT‐6), and Mycobacterium tuberculosis whole cell lysate (WCL) in human immunodeficiency virus (HIV)-infected and bacille Calmette‐Guérin (BCG)-immunized adults with CD4 cell counts of >or= 200 cells/μL who receivedplacebo in the DarDar tuberculosis vaccine trial in Tanzania. Subjects were followed prospectively to diagnose definite or probable tuberculosis. RESULTS:Tuberculosis was diagnosed in 92 of 979 subjects during a mean follow‐up of 3.2 years. The relative risk of tuberculosis among subjects with positive IFN‐γ responses to Ag85 was 0.51 (95% confidence interval [CI], 0.26-0.99; P = .049), to ESAT‐6 was 0.44 (95% CI, 0.23-0.85; P = .004), and to WCL was 0.67 (95% CI, 0.49-0.88; P = .002). The relative risk of tuberculosis was not significantly associated with baseline LPA responses. In a multivariate Cox regression model, subjects with IFN‐γ responses to ESAT‐6 and WCL had a lower hazard of developing tuberculosis, with a hazard ratio for ESAT‐6 of 0.35 (95% CI, 0.16–0.77; P = .009) and a hazard ratio for WCL of 0.30 (95% CI, 0.16-0.56; P < .001). CONCLUSIONS: Baseline IFN‐γ responses to ESAT-6 and WCL were associated with protection from subsequent tuberculosis among HIV-infected subjects with childhood BCG immunization in a region of high tuberculosis prevalence. Trial registration. ClinicalTrials.gov identifier: NCT00052195.
RCT Entities:
BACKGROUND: The cellular immune responses that protect against tuberculosis have not been identified. METHODS: We assessed baseline interferon γ (IFN‐γ) and lymphocyte proliferation assay (LPA) responses to antigen 85 (Ag85), early secretory antigenic target 6 (ESAT‐6), and Mycobacterium tuberculosis whole cell lysate (WCL) in humanimmunodeficiency virus (HIV)-infected and bacille Calmette‐Guérin (BCG)-immunized adults with CD4 cell counts of >or= 200 cells/μL who received placebo in the DarDar tuberculosis vaccine trial in Tanzania. Subjects were followed prospectively to diagnose definite or probable tuberculosis. RESULTS:Tuberculosis was diagnosed in 92 of 979 subjects during a mean follow‐up of 3.2 years. The relative risk of tuberculosis among subjects with positive IFN‐γ responses to Ag85 was 0.51 (95% confidence interval [CI], 0.26-0.99; P = .049), to ESAT‐6 was 0.44 (95% CI, 0.23-0.85; P = .004), and to WCL was 0.67 (95% CI, 0.49-0.88; P = .002). The relative risk of tuberculosis was not significantly associated with baseline LPA responses. In a multivariate Cox regression model, subjects with IFN‐γ responses to ESAT‐6 and WCL had a lower hazard of developing tuberculosis, with a hazard ratio for ESAT‐6 of 0.35 (95% CI, 0.16–0.77; P = .009) and a hazard ratio for WCL of 0.30 (95% CI, 0.16-0.56; P < .001). CONCLUSIONS: Baseline IFN‐γ responses to ESAT-6 and WCL were associated with protection from subsequent tuberculosis among HIV-infected subjects with childhood BCG immunization in a region of high tuberculosis prevalence. Trial registration. ClinicalTrials.gov identifier: NCT00052195.
Authors: S Lockman; J D Sheppard; C R Braden; M J Mwasekaga; C L Woodley; T A Kenyon; N J Binkin; M Steinman; F Montsho; M Kesupile-Reed; C Hirschfeldt; M Notha; T Moeti; J W Tappero Journal: J Clin Microbiol Date: 2001-03 Impact factor: 5.948
Authors: P W Lowry; T S Ludwig; J A Adams; M L Fitzpatrick; S M Grant; G A Andrle; M R Offerdahl; S N Cho; D R Jacobs Journal: J Infect Dis Date: 1998-07 Impact factor: 5.226
Authors: R D Waddell; C Chintu; A D Lein; A Zumla; M R Karagas; K S Baboo; J D Habbema; A N Tosteson; P Morin; S Tvaroha; R D Arbeit; A Mwinga; C F von Reyn Journal: Clin Infect Dis Date: 2000-06 Impact factor: 9.079
Authors: A M Elliott; T J Hurst; M N Balyeku; M A Quigley; P Kaleebu; N French; B Biryahwaho; J A Whitworth; H M Dockrell; R J Hayes Journal: Int J Tuberc Lung Dis Date: 1999-03 Impact factor: 2.373
Authors: C F von Reyn; C R Horsburgh; K N Olivier; P F Barnes; R Waddell; C Warren; S Tvaroha; A S Jaeger; A D Lein; L N Alexander; D J Weber; A N Tosteson Journal: Int J Tuberc Lung Dis Date: 2001-12 Impact factor: 2.373
Authors: Gillian F Black; Rosemary E Weir; Sian Floyd; Lyn Bliss; David K Warndorff; Amelia C Crampin; Bagrey Ngwira; Lifted Sichali; Bernadette Nazareth; Jenefer M Blackwell; Keith Branson; Steven D Chaguluka; Linda Donovan; Elizabeth Jarman; Elizabeth King; Paul E M Fine; Hazel M Dockrell Journal: Lancet Date: 2002-04-20 Impact factor: 79.321
Authors: Jenni M Vuola; Matti A Ristola; Bernard Cole; Annika Järviluoma; Susan Tvaroha; Terhi Rönkkö; Outi Rautio; Robert D Arbeit; C Fordham von Reyn Journal: AIDS Date: 2003-11-07 Impact factor: 4.177
Authors: Katalin A Wilkinson; Ronnett Seldon; Graeme Meintjes; Molebogeng X Rangaka; Willem A Hanekom; Gary Maartens; Robert J Wilkinson Journal: Am J Respir Crit Care Med Date: 2009-07-23 Impact factor: 21.405
Authors: Timothy Lahey; Robert D Arbeit; Muhammad Bakari; C Robert Horsburgh; Mecky Matee; Richard Waddell; Lillian Mtei; Jenni M Vuola; Kisali Pallangyo; C Fordham von Reyn Journal: Vaccine Date: 2010-09-25 Impact factor: 3.641
Authors: Timothy Lahey; Todd Mackenzie; Robert D Arbeit; Muhammad Bakari; Lillian Mtei; Mecky Matee; Isaac Maro; C Robert Horsburgh; Kisali Pallangyo; C Fordham von Reyn Journal: Clin Infect Dis Date: 2012-09-12 Impact factor: 9.079
Authors: Shruthi Ravimohan; Neo Tamuhla; Andrew P Steenhoff; Rona Letlhogile; Didimalang Kgomotso Makutu; Kebatshabile Nfanyana; Tumelo Rantleru; Ann Tierney; Kelebogile Nkakana; Adam B Schwartz; Robert Gross; Rob Roy Macgregor; Scarlett L Bellamy; Ian Frank; Drew Weissman; Gregory P Bisson Journal: J Infect Dis Date: 2013-08-01 Impact factor: 5.226
Authors: Timothy Lahey; Tom Czechura; Scott Crabtree; Robert D Arbeit; Mecky Matee; C Robert Horsburgh; Todd MacKenzie; Muhammad Bakari; Kisali Pallangyo; C Fordham von Reyn Journal: J Infect Dis Date: 2013-08-01 Impact factor: 5.226
Authors: Katrina M Pollock; Damien J Montamat-Sicotte; Graham S Cooke; Moses S Kapembwa; Onn M Kon; Lisa Grass; Robert D Sampson; Graham P Taylor; Ajit Lalvani Journal: Immun Inflamm Dis Date: 2015-04-29
Authors: Kondwani C Jambo; Dominic H Banda; Louise Afran; Anstead M Kankwatira; Rose D Malamba; Theresa J Allain; Stephen B Gordon; Robert S Heyderman; David G Russell; Henry C Mwandumba Journal: Am J Respir Crit Care Med Date: 2014-10-15 Impact factor: 21.405
Authors: Timothy Lahey; Brian K Mitchell; Robert D Arbeit; Siddharth Sheth; Mecky Matee; C Robert Horsburgh; Todd MacKenzie; Lillian Mtei; Muhammad Bakari; Jenni M Vuola; Kisali Pallangyo; C Fordham von Reyn Journal: PLoS One Date: 2011-07-20 Impact factor: 3.240